The Haystack Project
  • Home
  • Hospital Inpatient Hospital Outpatient Section 340b MACRA/QPP Patient Assistance Programs ICER Medicaid Other Issues
  • Letters Reports
  • News Events
  • Patient Stories
  • Join
  • About Us
  • Contact
  • Members Only
The Haystack Project
  • Home/
  • Issues/
    • Hospital Inpatient
    • Hospital Outpatient
    • Section 340b
    • MACRA/QPP
    • Patient Assistance Programs
    • ICER
    • Medicaid
    • Other Issues
  • Resources/
    • Letters
    • Reports
  • News/
    • News
    • Events
  • Patient Stories/
  • Join/
  • About Us/
  • Contact/
  • Members Only/
Newspapers.png
The Haystack Project

News

The Haystack Project
  • Home/
  • Issues/
    • Hospital Inpatient
    • Hospital Outpatient
    • Section 340b
    • MACRA/QPP
    • Patient Assistance Programs
    • ICER
    • Medicaid
    • Other Issues
  • Resources/
    • Letters
    • Reports
  • News/
    • News
    • Events
  • Patient Stories/
  • Join/
  • About Us/
  • Contact/
  • Members Only/

Articles of Interest to the Haystack Project Community

 
October 04, 2018

Should FDA Treat Rare Disease Drugs Differently? – Patient advocates, industry call for looser regulation→

October 04, 2018/ Saira Sultan
October 04, 2018/ Saira Sultan/ /Source

Saira Sultan

  • First Signs of Huntington’s Disease ...
  • MEDCAC Meeting 8/22/2018 - Chimeric ...

About Us

The Issues

Resources

News & Updates

© 2017 Haystack Project. All Rights Reserved. 

 

Join Us

Contact Us

The Haystack Project brings together Innovators dedicated to researching and developing treatments for extremely rare diseases with Patients suffering from or caring for them.

Our Mission:
Advocate for reimbursement policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.